Eytan Aharon Ben-ami
- Specjalizacja: Onkolog
- 20 lat doświadczenia
- Języki:English, Hebrew
- Konsultacje online: dostępne
- Miejsce pracy: Izrael, Ramat Gan, Centrum Medyczne Sheba
- Founded a Clinical Research Organization (CRO) leading early-phase clinical trials in sarcoma and bone oncology.
Dr. Eytan Aharon Ben-Ami leads the Oncology Division at Sheba Medical Center in Israel. He specialized in sarcoma and bone oncology at the Dana-Farber Cancer Institute. Dr. Ben-Ami founded the Sheba Clinical Research Organization to advance cancer studies. He treats rare bone tumors and soft tissue sarcomas with personalized protocols.
- Heads the Early-Phase Clinical Trials Unit for innovative cancer therapies.
- Authored over 40 scientific publications on molecular mechanisms and early detection.
- Leads Phase I trials in targeted therapy and immunotherapy for rare cancers.
- Works at Sheba Medical Center, a top-10 hospital globally per Newsweek.
Dr Eytan Aharon Ben-ami oferuje konsultacje online
Usługi lekarza
- Immunoterapia Keytruda (Pembrolizumab)
- Immunoterapia
- Chemioterapia
- Radioterapia
- Terapia celowana
- Złożone leczenie mięsaka Ewinga
- Immunoterapia przy mięsaku
- Resekcja kości
- Chemioterapia przy mięsakach
- Radioterapia przy mięsakach
- Terapia komórkami CAR-NK
- Terapia komórkami NK (komórki naturalnych zabójców)
- PET-CT
- TK (tomografia komputerowa)
- MRI całego ciała
- Biopsja
- Konsultacja online z onkologiem
- Badanie onkologiczne
- PET-CT z galem 68 (PSMA)
- Badanie krwi na obecność markerów nowotworowych
- PET-MRI
Jak Państwo oceniają naszą usługę?
Kwalifikacje
Dr. Eytan Aharon Ben-Ami is a medical oncologist at Sheba Medical Center. He founded the Sheba Clinical Research Organization to move early-phase cancer trials forward. He treats aggressive sarcomas and primary bone tumors.
Clinical Specialization and Rare Cancer Treatment
Dr. Ben-Ami treats malignancies of the soft tissue and bones. He helps patients with rare subtypes like liposarcoma and leiomyosarcoma. The doctor also treats primary bone tumors, including osteosarcoma and chondrosarcoma. He works with both pediatric and adult teams for these cases.
His approach uses targeted therapy and immunotherapy. These methods help him create treatment plans for rare cancers. Dr. Ben-Ami also applies CAR NK and Natural Killer cell therapies. These options provide alternatives for patients with diseases that are difficult to treat.
Leadership in Clinical Innovation
As Head of the Early-Phase Clinical Trials Unit, he leads Phase I studies. These trials give patients access to next-generation therapies. He also develops programs to improve care delivery. This work includes pilot projects for immunotherapy delivery in clinical settings.
Professional Experience
- Senior Physician, Sarcoma and Bone Oncology Service, Sheba Medical Center
- Head of Oncology Division, Sheba Medical Center
- Head of Early-Phase Clinical Trials Unit, Sheba Medical Center
- Founder, Sheba Clinical Research Organization (CRO)
- Academic Affiliate, Tel Aviv University
Education and Advanced Training
- Medical Degree (MD)
- Fellowship in Sarcoma and Bone Oncology, Dana-Farber Cancer Institute / Harvard Cancer Center
Scientific Research and Publications
Dr. Ben-Ami has authored over 40 scientific publications. His research focuses on the molecular and viral mechanisms of rare tumors. He also investigates methods for early sarcoma detection and monitoring. This scientific work helps develop oncology treatments for aggressive cancers.
Mogą Państwa również zainteresować
Płatność i nagrody
Państwo nie płacą za nasze usługi
Płatność jest dokonywana bezpośrednio w klinice lub na jej oficjalne konto bankowe.
Niektóre kliniki mogą wymagać wpłaty depozytu zgodnie ze swoją polityką.
Proszę płacić w ratach.
Proszę zapraszać znajomych do Bookimed i otrzymywać nagrody.